アラシ　ヒロユキ   Arashi Hiroyuki   嵐　弘之    所属   医学部 医学科（東京女子医科大学病院）    職種   寄附部門准教授
言語種別	英語
発表タイトル	Differences in the usefulness of aggressive lipid-­lowering therapy among single-vessel and multi-vessel coronary artery disease patients: HIJ-­PROPER sub-­study
会議名	ESC Congress 2019
主催者	European Society of Cardiology
学会区分	国際学会及び海外の学会
発表形式	ポスター掲示
講演区分	一般
発表者・共同発表者	OGISO Masataka, ◎NOMURA Hidekimi, NAKAZAWA Mayui, WATANABE Erisa, SEKIGUCHI Haruki, ARASHI Hiroyuki, YAMAGUCHI Junichi, OGAWA Hiroshi, HAGIWARA Nobuhisa,
発表年月日	2019/08/31
開催地 （都市, 国名）	Paris, FRANCE
概要	Poster Session 1: Acute coronary syndromes, coronary artery disease: treatment Topic : European Society Of Cardiology Session Type : Poster Session Conclusion: This study showed that ACS patients with SVD enjoyed significantly greater benefits from pitavastatin + ezetimibe therapy compared with pitavastatin monotherapy, whereas the patients with MVD did not. High rate of revascularization in acute phase of ACS might affect the efficacy of aggressive lipid­lowering therapy and our results in the present study suggest different treatment approach would be necessary in ACS patients with MVD in modern early invasive strategy era.